Biotest AG
Biotest AG: Biotest AG announces successful completion of Mutual Recognition Procedure for marketing authorization of Cytotect(R) CP Biotest in twelve European countries
DGAP-News: Biotest AG / Key word(s): Regulatory Approval / – Approval in four additional attractive European markets – Basis for future revenue growth with Cytotect(R) CP Biotest Dreieich, 21 August 2018. Biotest AG has announced today that the European Mutual Recognition Procedure (MRP) for its cytomegalovirus (CMV)-specific hyperimmunoglobulin preparation Cytotect(R) CP Biotest was successfully completed in twelve selected countries. “A declared objective of Biotest’s strategy is to tap into new attractive markets, in particular for specialty products such as Cytotect(R) CP Biotest to further develop our product portfolio”, explained Enrico D’Aiuto, VP Global Sales & Marketing of Biotest AG. “We are delighted with the positive decision of the authorities, so that we can now provide patients in twelve European countries with a unique drug for this serious infectious disease.” Biotest now expects the national marketing authorisations of Cytotect(R) CP Biotest to be issued promptly in the countries. Subsequently specific market launch activities are planned in the countries. Biotest AG expects that this will significantly increase revenues, especially in the new markets, and secure them across Europe in the long-term. About Cytotect(R) CP Biotest About Biotest IR contact PR contact Ordinary shares: securities’ ID No. 522720; ISIN DE0005227201 Disclaimer
21.08.2018 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English |
Company: | Biotest AG |
Landsteinerstraße 5 | |
63303 Dreieich | |
Germany | |
Phone: | 0 61 03 – 8 01-0 |
Fax: | 0 61 03 – 8 01-150 |
E-mail: | investor_relations@biotest.de |
Internet: | http://www.biotest.de |
ISIN: | DE0005227235, DE0005227201 |
WKN: | 522723, 522720 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
End of News | DGAP News Service |